Xenon Seven

Xenon Seven

Senior Manager/Associate Director, Enterprise Integration & Data Engineering

Boston · Director

Sponsorship not specifiedDetected 64 days ago
SnowflakeDatabricksAzureRESTMachine LearningdbtData EngineeringComplianceProject ManagementCRMSAPSupply ChainVendor ManagementERPHRISHIPAAClinical TrialsPatient CareResearchLeadershipCommunicationProblem SolvingGxP

About the role

  • We are seeking a Senior Manager/Associate Director, Enterprise Integration & Data Engineering to join our Information Technology (IT) team.
  • The successful candidate will combine hands-on technical depth with strong architecture, governance, vendor management, and cross-functional leadership skills.
  • This position reports to the Director, Data Architecture & Engineering and will be based out of Boston, MA, USA in our Needham office.

Responsibilities

  • Manage the implementation and maturation of Xenon's enterprise integration and data engineering capabilities, including middleware/iPaaS, API-based integration, event/message-based integration, file-based ingestion, and ELT/data pipeline patterns.
  • In consultation with assigned stakeholders, evaluate, select, implement, and govern integration and ELT platforms such as Informatica/IICS, Boomi, MuleSoft, Azure Integration Services, Fivetran, dbt, Snowflake, or similar technologies.
  • Design and oversee integrations and data pipelines between internal and external systems including ERP, Veeva CRM/Vault, commercial data providers, patient services platforms, EDC/clinical systems, safety systems, LIMS, eQMS, Dotmatics/ELN, HRIS/HCM, CLM, Concur, Adaptive Planning, banks, CDMOs/CMOs, 3PLs, and other partners.
  • Collaborate with Xenon's Architecture Review Board to ensure system and data-flow designs are consistent with company standards for security, infrastructure, data architecture, privacy, and operational supportability.
  • Partner with business data owners and data stewards to establish and maintain effective data governance including master data management, data quality, metadata, lineage, cataloging, access controls, and common data definitions across domains.
  • Ensure integration and data engineering solutions are designed with appropriate controls for GxP, SOX, HIPAA, GDPR, 21 CFR Part 11, auditability, data integrity, and role-based access, as applicable.
  • Provide technical guidance and support for Computer Systems Assurance (CSA), SDLC, regulatory/risk assessment, testing, validation, and change control deliverables for regulated systems and data flows.
  • Develop and manage the ongoing support model for integrations and data pipelines, including onboarding and managing qualified implementation partners and service providers.
  • Monitor integration and pipeline performance, manage operational issues to resolution, drive root cause analysis, and lead continuous improvement of platform reliability, scalability, cost efficiency, and support processes.
  • Translate business requirements into practical integration architecture, technical design, delivery plans, test strategies, and sustainable operating procedures.

Requirements

  • Hands-on experience with one or more integration or data platforms such as Informatica/IICS, Boomi, MuleSoft, Azure Integration Services, Fivetran, dbt, Snowflake, Databricks, or similar technologies.
  • Strong understanding of cloud data warehouse and analytics architectures, including source-to-target mapping, transformation logic, curated data layers, semantic models, and BI/analytics consumption patterns.
  • Ability to balance strategic architecture with pragmatic delivery in a growing, fast-paced organization
  • Strong problem-solving skills, attention to detail, and ability to simplify complex technical concepts for non-technical audiences.
  • A bachelor's degree or advanced degree in Information Systems, Computer Science, Data Engineering, Engineering, Business Administration, with a minimum of 7-10 year's prior experience with enterprise integration, data engineering, middleware, cloud data platform, analytics platform, or enterprise applications experience
  • Experience in a corporate IT environment is preferred. Related experience with service and/or solution providers is also relevant.
  • Experience in Life Sciences, pharmaceutical, biotechnology, healthcare, or another regulated industry is preferred. Direct pharma/biotech experience is valuable but not required if the candidate demonstrates strong enterprise integration, data engineering, cloud data platform.
  • Proven experience designing and delivering enterprise integrations, API integrations, batch/file-based interfaces, ELT/ETL pipelines, data orchestration, data quality checks, monitoring, and production support processes.
  • Experience integrating enterprise SaaS platforms and life-sciences systems such as ERP (Oracle Fusion or SAP S/4HANA), Veeva, Workday/HCM, CLM, Concur, Adaptive Planning, ServiceNow, eQMS, LIMS, EDC, ELN, clinical data repositories, or commercial data platforms.
  • comfortable building capability, standards, and operating models from the ground up.
  • Experience managing external consultants, implementation partners, managed service providers, and/or application service providers.
  • Excellent communication and coordination skills across business, technical, Quality, Security, and vendor teams.

Nice to have

  • Experience in a corporate IT environment is preferred.
  • Related experience with service and/or solution providers is also relevant.
  • Direct pharma/biotech experience is valuable but not required if the candidate demonstrates strong enterprise integration, data engineering, cloud data platform.
  • Experience with master data management, data governance, data stewardship, metadata, lineage, data cataloging, and data quality practices
  • MDM platform implementation experience is a plus.
  • Experience with Computer Systems Assurance, GxP systems validation, SDLC, 21 CFR Part 11, HIPAA, GDPR, SOX, audit trails, data integrity, and role-based access controls is preferred.
  • Project management experience
  • Agile, PMP, ITIL, cloud, data, or integration platform certifications are a plus.

Compensation

  • Our Total Rewards program includes base salary, target bonus, and stock options, as well as a full range of benefits including medical, dental, vision, short-& long-term disability, accidental death & dismemberment, and life insurance progr

Benefits

  • Partner with IT and business leaders to define and maintain an enterprise integration roadmap aligned to ERP, Commercial, Medical, Clinical, Research, Quality, MDM, and data warehouse priorities.

Company info

  • Xenon Pharmaceuticals (NASDAQ:XENE https://www.nasdaq.com/market-activity/stocks/xene) is a neuroscience-focused biopharmaceutical company dedicated to drug discovery, clinical development, and commercialization of life-changing therapeutics for patients in need. We are looking for great people who thrive in a respectful, collaborative, inclusive, and productive culture to join the Xenon team.
  • What We Do:
  • We are advancing an exciting product pipeline https://xenon-pharma.com/pipeline to address indications with high unmet medical need, including epilepsy, depression and pain. Our Phase 3 azetukalner program represents the most advanced, clinically validated potassium channel modulator in late-stage clinical development for multiple indications. In March 2026, we announced positive topline data from our Phase 3 X-TOLE2 study of azetukalner in focal onset seizures (FOS), and we anticipate submitting a New Drug Application to the Food and Drug Administration in the third quarter of 2026. Our Phase 3 epilepsy program also includes a second FOS study, X-TOLE3, which would support regulatory submissions outside the U.S., and the X-ACKT study in primary generalized tonic-clonic seizures, which would support regulatory submissions for an additional epilepsy indication. We also have multiple Phase 3 azetukalner clinical trials underway in major depressive disorder (MDD) and bipolar depression (BPD), based on topline data from our Phase 2 X-NOVA clinical trial. In addition, we are proud of our strong heritage in human genetics, deep understanding of ion channel biology, and expertise in novel chemistries to enable potent, selective ion channel targeting. We continue to advance an early-stage pipeline of novel therapeutic candidates, including Phase 1 studies for XEN1701 (targeting Nav1.7) and XEN1120 (targeting Kv7), which are important pain targets. Backed by a strong balance sheet to support our growth plans, we continue to build a fully integrated, premier neuroscience company with strong discovery, clinical development, corporate, and commercial operations.
  • Xenon Pharmaceuticals (NASDAQ:XENE https://www.nasdaq.com/market-activity/stocks/xene) is a neuroscience-focused biopharmaceutical company dedicated to drug discovery, clinical development, and commercialization of life-changing therapeutics for patients in need.
  • We are looking for great people who thrive in a respectful, collaborative, inclusive, and productive culture to join the Xenon team.
  • We are advancing an exciting product pipeline https://xenon-pharma.com/pipeline to address indications with high unmet medical need, including epilepsy, depression and pain.
  • Our Phase 3 azetukalner program represents the most advanced, clinically validated potassium channel modulator in late-stage clinical development for multiple indications.
  • In March 2026, we announced positive topline data from our Phase 3 X-TOLE2 study of azetukalner in focal onset seizures (FOS), and we anticipate submitting a New Drug Application to the Food and Drug Administration in the third quarter of 2026.
  • Our Phase 3 epilepsy program also includes a second FOS study, X-TOLE3, which would support regulatory submissions outside the U.S., and the X-ACKT study in primary generalized tonic-clonic seizures, which would support regulatory submissions for an additional epilepsy indication.
  • We also have multiple Phase 3 azetukalner clinical trials underway in major depressive disorder (MDD) and bipolar depression (BPD), based on topline data from our Phase 2 X-NOVA clinical trial.
  • In addition, we are proud of our strong heritage in human genetics, deep understanding of ion channel biology, and expertise in novel chemistries to enable potent, selective ion channel targeting.
  • We continue to advance an early-stage pipeline of novel therapeutic candidates, including Phase 1 studies for XEN1701 (targeting Nav1.7) and XEN1120 (targeting Kv7), which are important pain targets.
  • Backed by a strong balance sheet to support our growth plans, we continue to build a fully integrated, premier neuroscience company with strong discovery, clinical development, corporate, and commercial operations.
Apply directly at Xenon Seven →Create a free account for alerts like thisView Xenon Seven immigration profile

This listing is sourced directly from Xenon Seven's careers page and normalized into a canonical job model.